ROCKET PHARMACEUTICALS INC (RCKT) Stock Cash Flow
NASDAQ:RCKT - Nasdaq - US77313F1066 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -258.03M | -258.75M | -245.59M | -221.86M | -169.07M | |||
| Depreciation Amortization | 10.11M | 9.38M | 7.10M | 6.27M | 5.37M | |||
| Change In Working Capital | 772.00K | 1.92M | 13.46M | 6.08M | -3.39M | |||
| Interest Paid | N/A | N/A | 0.00 | 0.00 | 150.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 38.49M | 37.73M | 30.12M | 31.38M | 45.92M | |||
| OPERATING CASH FLOW | -208.66M | -209.72M | -194.92M | -178.14M | -121.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.19M | -5.86M | -16.47M | -8.62M | -7.72M | |||
| Other Investing Activity | 42.83M | 137.57M | -81.59M | -60.71M | 26.57M | |||
| INVESTING CASH FLOW | 38.64M | 131.71M | -98.07M | -69.33M | 18.85M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 184.56M | 185.74M | 208.40M | 155.29M | 37.68M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 184.56M | 185.74M | 208.40M | 155.29M | 37.68M | |||
| CHANGE IN CASH | 14.53M | 107.72M | -84.58M | -92.18M | -64.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -208.66M | -209.72M | -194.92M | -178.14M | -121.16M | |||
| Capital Expenditure | -4.19M | -5.86M | -16.47M | -8.62M | -7.72M | |||
| FREE CASH FLOW | -212.85M | -215.59M | -211.39M | -186.76M | -128.88M | |||
All data in USD